Compounds > pteridines
Page last updated: 2024-10-20

pteridines and Cancer of Spleen

pteridines has been researched along with Cancer of Spleen in 1 studies

Research Excerpts

ExcerptRelevanceReference
"The most common therapy for estrogen receptor-positive breast cancer is antihormone therapy, such as tamoxifen."7.88Essential Role of Polo-like Kinase 1 (Plk1) Oncogene in Tumor Growth and Metastasis of Tamoxifen-Resistant Breast Cancer. ( Bui, QT; Hong, J; Im, JH; Jeong, SB; Kang, KW; Lim, SC; Shim, Y; Song, JM; Yoon, JH; Yun, J, 2018)
"The most common therapy for estrogen receptor-positive breast cancer is antihormone therapy, such as tamoxifen."3.88Essential Role of Polo-like Kinase 1 (Plk1) Oncogene in Tumor Growth and Metastasis of Tamoxifen-Resistant Breast Cancer. ( Bui, QT; Hong, J; Im, JH; Jeong, SB; Kang, KW; Lim, SC; Shim, Y; Song, JM; Yoon, JH; Yun, J, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jeong, SB1
Im, JH1
Yoon, JH1
Bui, QT1
Lim, SC1
Song, JM1
Shim, Y1
Yun, J1
Hong, J1
Kang, KW1

Other Studies

1 other study available for pteridines and Cancer of Spleen

ArticleYear
Essential Role of Polo-like Kinase 1 (Plk1) Oncogene in Tumor Growth and Metastasis of Tamoxifen-Resistant Breast Cancer.
    Molecular cancer therapeutics, 2018, Volume: 17, Issue:4

    Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cell Cycle

2018